Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) has a relatively poor prognosis and a high degree of malignancy. However, the therapeutic drugs are limited. In recent years, abnormal lipid metabolism and its important role in HCC has been reported, and emerging studies found that some formulae and active components...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Liu, Jie Yang, Fenghua Yu, Li Li, Ning Zhao, Cheng Lu, Aiping Lu, Xiaojuan He
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1528671/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849712396473466880
author Yang Liu
Jie Yang
Fenghua Yu
Li Li
Ning Zhao
Cheng Lu
Aiping Lu
Aiping Lu
Aiping Lu
Xiaojuan He
author_facet Yang Liu
Jie Yang
Fenghua Yu
Li Li
Ning Zhao
Cheng Lu
Aiping Lu
Aiping Lu
Aiping Lu
Xiaojuan He
author_sort Yang Liu
collection DOAJ
description Hepatocellular carcinoma (HCC) has a relatively poor prognosis and a high degree of malignancy. However, the therapeutic drugs are limited. In recent years, abnormal lipid metabolism and its important role in HCC has been reported, and emerging studies found that some formulae and active components of traditional Chinese medicine (TCM) can regulate abnormal lipid metabolism in HCC, showing their good application prospects. Therefore, this article summarizes the changes and the roles of lipid metabolites in HCC progression, and discusses the role of formulae and active components of TCM for the treatment of HCC based on their regulation on abnormal lipid metabolism. A deeper understanding of their relationship may help the precise use of these formulae and active components in HCC.
format Article
id doaj-art-c8082637086e48199d2e91c30fcd550d
institution DOAJ
issn 1663-9812
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-c8082637086e48199d2e91c30fcd550d2025-08-20T03:14:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-04-011610.3389/fphar.2025.15286711528671Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapyYang Liu0Jie Yang1Fenghua Yu2Li Li3Ning Zhao4Cheng Lu5Aiping Lu6Aiping Lu7Aiping Lu8Xiaojuan He9Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaLaw Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong SAR, ChinaInstitute of Systems Medicine and Health Sciences, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong SAR, ChinaShanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Institute of Arthritis Research, Shanghai Academy of Chinese Medical Sciences, Shanghai, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaHepatocellular carcinoma (HCC) has a relatively poor prognosis and a high degree of malignancy. However, the therapeutic drugs are limited. In recent years, abnormal lipid metabolism and its important role in HCC has been reported, and emerging studies found that some formulae and active components of traditional Chinese medicine (TCM) can regulate abnormal lipid metabolism in HCC, showing their good application prospects. Therefore, this article summarizes the changes and the roles of lipid metabolites in HCC progression, and discusses the role of formulae and active components of TCM for the treatment of HCC based on their regulation on abnormal lipid metabolism. A deeper understanding of their relationship may help the precise use of these formulae and active components in HCC.https://www.frontiersin.org/articles/10.3389/fphar.2025.1528671/fullhepatocellular carcinomalipid metabolismtraditional Chinese medicineformulaeactive components
spellingShingle Yang Liu
Jie Yang
Fenghua Yu
Li Li
Ning Zhao
Cheng Lu
Aiping Lu
Aiping Lu
Aiping Lu
Xiaojuan He
Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
Frontiers in Pharmacology
hepatocellular carcinoma
lipid metabolism
traditional Chinese medicine
formulae
active components
title Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
title_full Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
title_fullStr Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
title_full_unstemmed Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
title_short Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
title_sort research advances in traditional chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
topic hepatocellular carcinoma
lipid metabolism
traditional Chinese medicine
formulae
active components
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1528671/full
work_keys_str_mv AT yangliu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT jieyang researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT fenghuayu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT lili researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT ningzhao researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT chenglu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT aipinglu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT aipinglu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT aipinglu researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy
AT xiaojuanhe researchadvancesintraditionalchinesemedicineformulaeandactivecomponentstargetinglipidmetabolismforhepatocellularcarcinomatherapy